vs
Side-by-side financial comparison of RHYTHM PHARMACEUTICALS, INC. (RYTM) and TELOS CORP (TLS). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $46.8M, roughly 1.2× TELOS CORP). TELOS CORP runs the higher net margin — -34.9% vs -83.0%, a 48.1% gap on every dollar of revenue. On growth, TELOS CORP posted the faster year-over-year revenue change (77.4% vs 36.9%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 25.7%).
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
Telos Corporation is an information technology and cybersecurity company located in Ashburn, Virginia. Telos primarily serves government and enterprise clients, receiving a large number of its contracts from the United States Department of Defense. Customers are primarily military, intelligence and civilian agencies of the US government and NATO allies.
RYTM vs TLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.3M | $46.8M |
| Net Profit | $-47.5M | $-16.3M |
| Gross Margin | 91.6% | 35.0% |
| Operating Margin | -82.2% | -39.6% |
| Net Margin | -83.0% | -34.9% |
| Revenue YoY | 36.9% | 77.4% |
| Net Profit YoY | -9.6% | -74.8% |
| EPS (diluted) | $-0.73 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $57.3M | $46.8M | ||
| Q3 25 | $51.3M | $51.4M | ||
| Q2 25 | $48.5M | $36.0M | ||
| Q1 25 | $32.7M | $30.6M | ||
| Q4 24 | $41.8M | $26.4M | ||
| Q3 24 | $33.3M | $23.8M | ||
| Q2 24 | $29.1M | $28.5M | ||
| Q1 24 | $26.0M | $29.6M |
| Q4 25 | $-47.5M | $-16.3M | ||
| Q3 25 | $-52.9M | $-2.1M | ||
| Q2 25 | $-46.6M | $-9.5M | ||
| Q1 25 | $-49.5M | $-8.6M | ||
| Q4 24 | $-43.3M | $-9.3M | ||
| Q3 24 | $-43.6M | $-28.1M | ||
| Q2 24 | $-32.3M | $-7.8M | ||
| Q1 24 | $-141.4M | $-7.4M |
| Q4 25 | 91.6% | 35.0% | ||
| Q3 25 | 89.3% | 39.9% | ||
| Q2 25 | 88.6% | 33.2% | ||
| Q1 25 | 88.8% | 39.8% | ||
| Q4 24 | 90.9% | 40.3% | ||
| Q3 24 | 88.5% | 13.2% | ||
| Q2 24 | 89.9% | 34.1% | ||
| Q1 24 | 89.2% | 37.0% |
| Q4 25 | -82.2% | -39.6% | ||
| Q3 25 | -102.6% | -4.8% | ||
| Q2 25 | -93.4% | -27.5% | ||
| Q1 25 | -143.7% | -29.5% | ||
| Q4 24 | -98.6% | -37.6% | ||
| Q3 24 | -132.0% | -121.4% | ||
| Q2 24 | -139.2% | -30.3% | ||
| Q1 24 | -538.7% | -28.5% |
| Q4 25 | -83.0% | -34.9% | ||
| Q3 25 | -103.1% | -4.1% | ||
| Q2 25 | -96.1% | -26.5% | ||
| Q1 25 | -151.4% | -28.1% | ||
| Q4 24 | -103.6% | -35.4% | ||
| Q3 24 | -131.2% | -118.0% | ||
| Q2 24 | -110.9% | -27.2% | ||
| Q1 24 | -544.4% | -24.9% |
| Q4 25 | $-0.73 | $-0.22 | ||
| Q3 25 | $-0.82 | $-0.03 | ||
| Q2 25 | $-0.75 | $-0.13 | ||
| Q1 25 | $-0.81 | $-0.12 | ||
| Q4 24 | $-0.71 | $-0.13 | ||
| Q3 24 | $-0.73 | $-0.39 | ||
| Q2 24 | $-0.55 | $-0.11 | ||
| Q1 24 | $-2.35 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $388.9M | $53.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $139.1M | $96.0M |
| Total Assets | $480.2M | $139.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $388.9M | $53.2M | ||
| Q3 25 | $416.1M | $59.0M | ||
| Q2 25 | $291.0M | $57.0M | ||
| Q1 25 | $314.5M | $57.8M | ||
| Q4 24 | $320.6M | $54.6M | ||
| Q3 24 | $298.4M | $69.8M | ||
| Q2 24 | $319.1M | $80.1M | ||
| Q1 24 | $201.2M | $93.9M |
| Q4 25 | $139.1M | $96.0M | ||
| Q3 25 | $148.8M | $119.7M | ||
| Q2 25 | $-11.9M | $118.4M | ||
| Q1 25 | $18.9M | $126.1M | ||
| Q4 24 | $21.7M | $127.1M | ||
| Q3 24 | $11.2M | $129.5M | ||
| Q2 24 | $39.3M | $149.1M | ||
| Q1 24 | $61.6M | $154.4M |
| Q4 25 | $480.2M | $139.9M | ||
| Q3 25 | $506.9M | $164.3M | ||
| Q2 25 | $372.7M | $165.0M | ||
| Q1 25 | $386.7M | $158.1M | ||
| Q4 24 | $392.3M | $158.2M | ||
| Q3 24 | $363.6M | $166.3M | ||
| Q2 24 | $381.8M | $182.4M | ||
| Q1 24 | $258.7M | $195.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.4M | $8.0M |
| Free Cash FlowOCF − Capex | — | $8.0M |
| FCF MarginFCF / Revenue | — | 17.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $29.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.4M | $8.0M | ||
| Q3 25 | $-26.6M | $9.1M | ||
| Q2 25 | $-23.3M | $7.0M | ||
| Q1 25 | $-40.4M | $6.1M | ||
| Q4 24 | $-18.8M | $-10.5M | ||
| Q3 24 | $-25.2M | $-7.1M | ||
| Q2 24 | $-29.1M | $-8.0M | ||
| Q1 24 | $-40.7M | $-350.0K |
| Q4 25 | — | $8.0M | ||
| Q3 25 | — | $8.7M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | — | $-12.4M | ||
| Q3 24 | — | $-7.1M | ||
| Q2 24 | — | $-8.2M | ||
| Q1 24 | — | $-447.0K |
| Q4 25 | — | 17.0% | ||
| Q3 25 | — | 16.9% | ||
| Q2 25 | — | 19.0% | ||
| Q1 25 | — | 19.5% | ||
| Q4 24 | — | -47.0% | ||
| Q3 24 | — | -30.0% | ||
| Q2 24 | — | -28.9% | ||
| Q1 24 | — | -1.5% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 7.1% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 0.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RYTM
Segment breakdown not available.
TLS
| Security Solutions Segment | $44.8M | 96% |
| Secure Networks Segment | $1.9M | 4% |
